Drugs Made In America Acquisition (DMAA) vs Velos Acquisition I (VLOS)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Drugs Made In America Acquisition is the larger company by market cap ($263.4 million vs $253.2 million), about 1.0 times the size. On valuation, Drugs Made In America Acquisition trades at a lower trailing P/E (60.3x vs 98.1x for Velos Acquisition I).
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | DMAA | VLOS |
|---|---|---|
| Share price | $10.85 | $10.79 |
| Market cap | $263.40M | $253.25M |
| 1-day change | +0.18% | +0.28% |
| P/E ratio (TTM) | 60.28 | 98.09 |
| EPS (TTM) | $0.18 | $0.11 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $10.89 | $11.96 |
| 52-week low | $10.26 | $9.10 |
| Distance from 52-week high | -0.37% | -9.78% |
| Average volume | 21.20K | 35.83K |
| Shares outstanding | 24.28M | 23.47M |
| Sector | Financial Services | Financial Services |
| Industry | Shell Companies | Shell Companies |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- Velos Acquisition I trades at a higher earnings multiple (98.1x vs 60.3x trailing P/E).
About Drugs Made In America Acquisition
DMAA stock →Drugs Made In America Acquisition Corp. does not have significant operations.
Financial Services · Shell Companies
About Velos Acquisition I
VLOS stock →Velos Acquisition I Corp. does not have significant operations.
Financial Services · Shell Companies
DMAA vs VLOS FAQ
Which is bigger, Drugs Made In America Acquisition or Velos Acquisition I?
Drugs Made In America Acquisition (DMAA) is larger, with a market capitalization of $263.40M compared with $253.25M for Velos Acquisition I (VLOS).
Which has the lower P/E ratio, DMAA or VLOS?
DMAA has the lower trailing P/E at 60.3, versus 98.1 for VLOS. A lower P/E is not by itself a sign of a better investment; it can reflect slower expected growth or higher risk.
Are Drugs Made In America Acquisition and Velos Acquisition I in the same industry?
Yes. Both are classified in the Shell Companies industry within the Financial Services sector.